Cell Rep . The Human Leukocyte Antigen Class II Immunopeptidome of the SARS-CoV-2 Spike Glycoprotein

[tetano]

Cell Rep


. 2020 Nov 13;108454.
doi: 10.1016/j.celrep.2020.108454. Online ahead of print.
The Human Leukocyte Antigen Class II Immunopeptidome of the SARS-CoV-2 Spike Glycoprotein


Michael D Knierman ¹ , Megan B Lannan ¹ , Laura J Spindler ¹ , Carl L McMillian ¹ , Robert J Konrad ¹ , Robert W Siegel ²



Affiliations

• PMID: 33220791
• DOI: 10.1016/j.celrep.2020.108454

Free article

Abstract

Precise elucidation of the antigen sequences for T cell immunosurveillance greatly enhances our ability to understand and modulate humoral responses to viral infection or active immunization. Mass spectrometry is used to identify 526 unique sequences from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike glycoprotein extracellular domain in a complex with human leukocyte antigen class II molecules on antigen-presenting cells from a panel of healthy donors selected to represent a majority of allele usage from this highly polymorphic molecule. The identified sequences span the entire spike protein, and several sequences are isolated from a majority of the sampled donors, indicating promiscuous binding. Importantly, many peptides derived from the receptor binding domain used for cell entry are identified. This work represents a precise and comprehensive immunopeptidomic investigation with the SARS-CoV-2 spike glycoprotein and allows detailed analysis of features that may aid vaccine development to end the current coronavirus disease 2019 (COVID-19) pandemic.

Keywords: COVID-19; HLA-II; MAPPs; coronavirus; dendritic cell; immune response; immunopeptidomics; mass spectrometry; peptide; spike glycoprotein.